HS patients group (n=47) | Percentage (%) | |
---|---|---|
Age ( μ±σ ) | 39,64±15,16 | x |
Sex (male/female ) | 25/22 | 53,19/46,81 |
Body Mass index(BMI) ( μ±σ kg/m2 ) | 28,68±3,21 | x |
Disease duration ( μ±σ years ) | 7,27±4,98 | x |
Hurley stage III | 47 | 100 |
HS-Sonografic scoring (SOS) stage III | 47 | 100 |
HS- Physician Global | ||
Assessment (PGA) | ||
|
|
|
Dermatological Life Quality Index (DLQI) (μ±σ ) | 22,83±3,13 | x |
Autoinflammatory disease damage index (ADDI) items | HS patients | Percentage (%) |
---|---|---|
Reproductive | 22 | 46,80 |
Sub/infertility | 17 | 36,17 |
Amenorrhoea | 5 | 10,64 |
Renal/amyloidosis | 12 | 25,53 |
Amyloidosis | ||
|
|
|
Proteinuria | 7 | 14,89 |
Renal insufficiency | ||
|
|
|
Developmental | 18 | 38,3 |
Growth failure | 3 | 6,38 |
Puberty delay | 15 | 31,91 |
Serosal | 3 | 6,38 |
Serosal scarring | 3 | 6,38 |
Neurological | 9 | 19,15 |
Developmental delay | 0 | 0 |
Cognitive impairment* | 9 | 19,15 |
Elevated intracranial pressure | 0 | 0 |
Central nervous system involvement | 0 | 0 |
Ears | 1 | 2,13 |
Hearing loss | ||
|
|
|
Ocular | 11 | 23,40 |
Ocular involvement | ||
|
|
|
Musculoskeletal | 46 | 97,87 |
Joint restriction | 12 | 25,53 |
Bone deformity | 6 | 12,77 |
Osteoporosis | 20 | 42,55 |
Musculoskeletal pain | 44 | 93,62 |
ADDI Points ( μ±σ ) | 7,27±4,98 | x |
Autoimmune/Autoinflammatory comorbidities | 12 Chron's disease: 6 Pyoderma gangrenosum: 2 Spondyloarthropathy :2 Psoriasis: 1 Hashimoto's thyroiditis: 1 | 25,53 |
* Cognitive impairment was calculated as positive if IQ<80 as defined by neuropsychological assessment, namely Wechsler Intelligence Scale for Adults (WAIS) IV, or if Mini-Mental State Examination (MMSE) results in a score<23.